The assessment of a psychosocial treatment with chronic schizophrenic patients using neuropsychopharmacological indices.
The current investigation explored and compared the genotypic neuropsychopharmacological indices of eight chronic schizophrenic patients and four therapists on an inductive paradigm. Patients and normals were screened with clinical interviews, psychometric and psychophysiological tests and neuroleptic availability radioreceptor assays were monitored within a three month pre-post treatment design. Results revealed that clinical, psychometric and psychophysiological parameters failed to reach statistical significance in a three month pre-post treatment structure and functional comparison. The implications for future schizophrenia research are discussed and illustrated using actual neuropsychophysiological phenotypic and genotypic profiles of introverted, extroverted and ambivert schizophrenic patients.
D002908:Chronic Disease; D005260:Female; D006220:Haloperidol / Q000097:blood; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D011600:Psychopharmacology; D011869:Radioligand Assay; D012559:Schizophrenia / Q000503:physiopathology / Q000628:therapy*
D006220:Haloperidol